Results 61 to 70 of about 90,842 (160)

Basaloid squamous cell carcinoma of the head and neck: Our experience

Journal of Head & Neck Physicians and Surgeons, 2020
Basaloid squamous cell carcinoma (BSCC) of the head and neck is a distinctive variant of squamous cell carcinoma known for its basaloid appearance and aggressive behavior.
Jaimanti Bakshi, Anil K Dash, Naresh K Panda, Amanjit Bal, Debajyoti Chatterjee, Sourabha K Patro   +5 more
doaj   +1 more source

Measuring the response of human head and neck squamous cell carcinoma to irradiation in a microfluidic model allowing customized therapy [PDF]

, 2017
Radiotherapy is the standard treatment for head and neck squamous cell carcinoma (HNSCC), however, radioresistance remains a major clinical problem despite significant improvements in treatment protocols. Therapeutic outcome could potentially be improved
Beavis, Andrew W., Cheah, Ramsah, Green, Victoria, Greenman, John, Srivastava, Rishi, Stafford, Nicholas D.   +5 more
core   +1 more source

Easily detected signs of perineural tumour spread in head and neck cancer

Insights into Imaging, 2018
Perineural tumour spread (PNTS) in head and neck oncology is most often caused by squamous cell carcinoma. The most frequently affected nerves are the trigeminal and facial nerves. Up to 40% of patients with PNTS may be asymptomatic. Therefore, the index
Jan Willem Dankbaar, Frank A. Pameijer, Jeroen Hendrikse, Ilona M. Schmalfuss   +3 more
doaj   +1 more source

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA

Сибирский онкологический журнал, 2016
We compared the serum proteome profiles of squamous cell head and neck carcinoma patients with metastases, without metastases and healthy volunteers using the combination of gradient gel-electrophoresis (1D-SDS PAGE) and mass-spectrometry.
G. V. Kakurina, I. V. Kondakova, E. L. Choinzonov, D. A. Shishkin, O. V. Cheremisina   +4 more
doaj  

SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. [PDF]

, 2019
BACKGROUND:Programmed cell death ligand-1 (PD-L1) expression on tumor cells (TCs) is associated with improved survival in patients with head and neck squamous cell carcinoma (HNSCC) treated with immunotherapy, although its role as a prognostic factor is ...
Baste, Neus, Clayburgh, Daniel, Cohen, Ezra EW, Fountzilas, George, Fujii, Takashi, Khaliq, Asud, Kim, Edward S, Lin, Derrick, Lipworth, Loren, Mehlhorn, Holger, Melillo, Giovanni, Pai, Sara I, Resteghini, Carlo, Shara, Nawar, Shire, Norah, Stokes, Michael, Twumasi-Ankrah, Philip, Wang, Huifen, Wildsmith, Sophie, Zhang, Jun   +19 more
core   +1 more source

Computational methods reveal novel functionalities of PIWI-interacting RNAs in human papillomavirus-induced head and neck squamous cell carcinoma. [PDF]

, 2017
Human papillomavirus (HPV) infection is the fastest growing cause of head and neck squamous cell carcinoma (HNSCC) today, but its role in malignant transformation remains unclear.
Califano, Joseph A, Krishnan, Aswini R, Li, Pin Xue, Ongkeko, Weg M, Qu, Yuanhao, Wang-Rodriguez, Jessica, Zou, Angela E   +6 more
core   +1 more source

Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry

The Journal of Pathology: Clinical Research, 2022
The differentiation between a pulmonary metastasis and a newly developed squamous cell carcinoma of the lung in patients with prior head and neck squamous cell carcinoma (HNSCC) is difficult due to a lack of biomarkers but is crucially important for the ...
Annika Richter, Alexander Fichtner, Jasmin Joost, Philipp Brockmeyer, Philipp Kauffmann, Henning Schliephake, Alexander Hammerstein‐Equord, Stefan Kueffer, Henning Urlaub, Thomas Oellerich, Philipp Ströbel, Hanibal Bohnenberger, Felix Bremmer   +12 more
doaj   +1 more source

A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery. [PDF]

, 2018
Purpose: To review brachytherapy use in recurrent head and neck carcinoma (RHNC) with focus on its efficacy and complication rates. Material and methods: A literature search of PubMed, Ovid, Google Scholar, and Scopus was conducted from 1990 to 2017 ...
Bar-Ad, Voichita, Cognetti, David, Curry, Joseph, Doyle, Laura, Johnson, Jennifer, Keane, William M., Kutler, David, Leiby, Benjamin E., Luginbuhl, Adam J., Rodin, Julianna, Zender, Chad   +10 more
core   +1 more source

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. [PDF]

, 2011
BACKGROUND: Surgery is an important part of the management of oral cavity cancer with regard to both the removal of the primary tumour and removal of lymph nodes in the neck. Surgery is less frequently used in oropharyngeal cancer.
Bessell, A, Clarkson, JE, Conway, DI, Furness, S, Glenny, A-M, Macluskey, M, Oliver, R, Pavitt, S, Sloan, P, Worthington, HV   +9 more
core   +3 more sources

Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy

Frontiers in Oncology
Recent strides in understanding the molecular underpinnings of head and neck cancers have sparked considerable interest in identifying precise biomarkers that can enhance prognostication and enable personalized treatment strategies.
Kamal S. Saini, Kamal S. Saini, Sasikala Somara, Heidi C. Ko, Purva Thatai, Angela Quintana, Zachary D. Wallen, Michelle F. Green, Ravi Mehrotra, Sandra McGuigan, Lingjuan Pang, Soma Das, Kavita Yadav, Dobrica Neric, Luca Cantini, Chinmayee Joshi, Kazuya Iwamoto, Sudha Dubbewar, Laura Vidal, Isagani Chico, Eric Severson, Luigi Lorini, Sunil Badve, Paolo Bossi, Paolo Bossi   +24 more
doaj   +1 more source